Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin add-on to Alogliptin in T2DM
NCT02068443Phase 3Completed
- Sponsor
- Takeda
- Start
- Feb 2014
- Primary completion
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of alogliptin, metformin in type 2 diabetes mellitus (T2DM), sponsored by Takeda. Started Feb 2014; status: completed.
02
Drugs
alogliptinmetformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02068443.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02068443.